Magnetic Calcium Phosphate Cement for Hyperthermia Treatment of Bone Tumors
This article reports, for the first time, the ‘proof-of-concept’ results on magnetic monetite (CaHPO<sub>4</sub>)-based calcium phosphate cements (CPCs) compositions developed for the hyperthermia treatment of bone tumors. Hyperthermia involves the heating of a tumor within a temperature...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Materials |
Subjects: | |
Online Access: | https://www.mdpi.com/1996-1944/13/16/3501 |
_version_ | 1797559567967584256 |
---|---|
author | Ethel Ibinabo Ruskin Paritosh Perry Coomar Prabaha Sikder Sarit B. Bhaduri |
author_facet | Ethel Ibinabo Ruskin Paritosh Perry Coomar Prabaha Sikder Sarit B. Bhaduri |
author_sort | Ethel Ibinabo Ruskin |
collection | DOAJ |
description | This article reports, for the first time, the ‘proof-of-concept’ results on magnetic monetite (CaHPO<sub>4</sub>)-based calcium phosphate cements (CPCs) compositions developed for the hyperthermia treatment of bone tumors. Hyperthermia involves the heating of a tumor within a temperature range of 40–45 °C, inducing apoptosis in the tumor cells. This process holds promising potential in the field of cancer treatment and has been proven to be more effective than conventional therapeutics. Hence, we aimed to develop cement compositions that are capable of the hyperthermia treatment of bone tumors. To achieve that central goal, we incorporated iron oxide (Fe<sub>3</sub>O<sub>4</sub>), a ferromagnetic material, into monetite and hypothesized that, upon the application of a magnetic field, magnetite will generate heat and ablate the tumor cells near the implantation site. The results confirmed that an optimized content of magnetite incorporation in monetite can generate heat in the range of 40–45 °C upon the application of a magnetic field. Furthermore, the compositions were bioactive and cytocompatible with an osteoblastic cell line. |
first_indexed | 2024-03-10T17:47:11Z |
format | Article |
id | doaj.art-bd5dfcaac68847159459fc4c3c1a242a |
institution | Directory Open Access Journal |
issn | 1996-1944 |
language | English |
last_indexed | 2024-03-10T17:47:11Z |
publishDate | 2020-08-01 |
publisher | MDPI AG |
record_format | Article |
series | Materials |
spelling | doaj.art-bd5dfcaac68847159459fc4c3c1a242a2023-11-20T09:30:22ZengMDPI AGMaterials1996-19442020-08-011316350110.3390/ma13163501Magnetic Calcium Phosphate Cement for Hyperthermia Treatment of Bone TumorsEthel Ibinabo Ruskin0Paritosh Perry Coomar1Prabaha Sikder2Sarit B. Bhaduri3Department of Mechanical Industrial & Manufacturing Engineering, The University of Toledo, Toledo, OH 43606, USACollege of Literature, Sciences & Arts, University of Michigan, Ann Arbor, MI 48109, USADepartment of Mechanical Industrial & Manufacturing Engineering, The University of Toledo, Toledo, OH 43606, USADepartment of Mechanical Industrial & Manufacturing Engineering, The University of Toledo, Toledo, OH 43606, USAThis article reports, for the first time, the ‘proof-of-concept’ results on magnetic monetite (CaHPO<sub>4</sub>)-based calcium phosphate cements (CPCs) compositions developed for the hyperthermia treatment of bone tumors. Hyperthermia involves the heating of a tumor within a temperature range of 40–45 °C, inducing apoptosis in the tumor cells. This process holds promising potential in the field of cancer treatment and has been proven to be more effective than conventional therapeutics. Hence, we aimed to develop cement compositions that are capable of the hyperthermia treatment of bone tumors. To achieve that central goal, we incorporated iron oxide (Fe<sub>3</sub>O<sub>4</sub>), a ferromagnetic material, into monetite and hypothesized that, upon the application of a magnetic field, magnetite will generate heat and ablate the tumor cells near the implantation site. The results confirmed that an optimized content of magnetite incorporation in monetite can generate heat in the range of 40–45 °C upon the application of a magnetic field. Furthermore, the compositions were bioactive and cytocompatible with an osteoblastic cell line.https://www.mdpi.com/1996-1944/13/16/3501magnetic calcium phosphate cementmagnetitehyperthermia |
spellingShingle | Ethel Ibinabo Ruskin Paritosh Perry Coomar Prabaha Sikder Sarit B. Bhaduri Magnetic Calcium Phosphate Cement for Hyperthermia Treatment of Bone Tumors Materials magnetic calcium phosphate cement magnetite hyperthermia |
title | Magnetic Calcium Phosphate Cement for Hyperthermia Treatment of Bone Tumors |
title_full | Magnetic Calcium Phosphate Cement for Hyperthermia Treatment of Bone Tumors |
title_fullStr | Magnetic Calcium Phosphate Cement for Hyperthermia Treatment of Bone Tumors |
title_full_unstemmed | Magnetic Calcium Phosphate Cement for Hyperthermia Treatment of Bone Tumors |
title_short | Magnetic Calcium Phosphate Cement for Hyperthermia Treatment of Bone Tumors |
title_sort | magnetic calcium phosphate cement for hyperthermia treatment of bone tumors |
topic | magnetic calcium phosphate cement magnetite hyperthermia |
url | https://www.mdpi.com/1996-1944/13/16/3501 |
work_keys_str_mv | AT ethelibinaboruskin magneticcalciumphosphatecementforhyperthermiatreatmentofbonetumors AT paritoshperrycoomar magneticcalciumphosphatecementforhyperthermiatreatmentofbonetumors AT prabahasikder magneticcalciumphosphatecementforhyperthermiatreatmentofbonetumors AT saritbbhaduri magneticcalciumphosphatecementforhyperthermiatreatmentofbonetumors |